Daniel Barber sold $551K of Aquestive Therapeutics (AQST)

Executed Sep 26 2025, disclosed Sep 29 2025, 3 days later.

Value, as filed

$551K

91,343 sh × $6.03

Executed

Sep 26 2025

the trade date, as filed

Disclosed

Sep 29 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DB Daniel Barber President and CEO profile →

Daniel Barber (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Aquestive Therapeutics, Inc. (AQST). The largest single filing was $753K of AQST (180,677 sh × $4.17, as filed), executed Mar 10.

The name

AQST Aquestive Therapeutics, Inc. AQST · Healthcare · 14 filings in 24 months ticker →

Healthcare · Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Daniel Barber in AQST

AQSTSALE Aquestive Therapeutics, Inc. $120K
25,000 sh × $4.82
Exec Sep 15
Filed Sep 16 · 2:00 PM ET AQSTSALE Aquestive Therapeutics, Inc. $107K
25,000 sh × $4.29
Exec Aug 17
Filed Aug 18 · 4:13 PM ET AQSTSALE Aquestive Therapeutics, Inc. $104K
25,000 sh × $4.16
Exec Jun 15
Filed Jun 16 · 5:30 PM ET AQSTSALE Aquestive Therapeutics, Inc. $753K
180,677 sh × $4.17
Exec Mar 10
Filed Mar 11 · 5:30 PM ET